Ivabradine, a heart rate slowing drug used to treat heart failure and (in Europe) angina, had varying impacts upon cardiovascular events in its three large outcome trials. FDA analyses may explain the reasons for the variability.
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
Ivabradine, a heart rate slowing drug used to treat heart failure and (in Europe) angina, had varying impacts upon cardiovascular events in its three large outcome trials. FDA analyses may explain the reasons for the variability.